Table 1.
Clinical Characteristics and Treatments of Patients
| Variables | At Admission Median (min-max) |
|---|---|
| WBC (103/µL) | 9.14 (3.27-32.63) |
| Hemoglobin (g/dL) | 14 (8.3-1.6.2) |
| Platelet (103/µL) | 234 (99-464) |
| Urea (mg/dL) | 53.5 (20-115) |
| Creatinine (mg/dL) | 0.84 (0.54-3.1) |
| Na (mEq/L) | 138 (132-143) |
| Phosphorus (mg/dL) | 2.9 (1.1-5.4) |
| INR | 1.55 (0.9-4.5) |
| Total bilirubin (mg/dL) | 1.62 (0.1-7.86) |
| AST (U/L) | 1409 (51-5869) |
| ALT (U/L) | 1596.5 (48-8450) |
| ALP (U/L) | 95 (52-409) |
| GGT (U/L) | 37.5 (9-347) |
| MELD Score | 18.5 (6-39) |
| Symptoms | n (%) |
| Nausea-vomiting | 23 (95.8) |
| Diarrhea | 15 (62.5) |
| Abdominal pain | 12 (50) |
| Treatments | n (%) |
| NAC | 4 (16.7) |
| NAC + Pen G | 6 (25) |
| NAC + Silymarin | 2 (8.3) |
| NAC + Pen G + Silymarin | 5 (20.8) |
| NAC + Plasmapheresis | 1 (4.2) |
| NAC + Pen G + Plasmapheresis | 2 (8.3) |
| NAC + Silymarin + Plasmapheresis | 2 (8.3) |
| NAC + Pen G + Silymarin + Plasmapheresis | 2 (8.3) |
WBC, white blood cell; INR, international normalized ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transferase; MELD, Model for End-stage Liver Disease; NAC, n-acetylcysteine, Pen G; penicillin G.